ABCL logo

AbCellera Biologics (ABCL) Cash From Operations

Annual CFO

-$108.56 M
-$64.68 M-147.41%

December 31, 2024


Summary


Performance

ABCL Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherABCLcash flowmetrics:

Quarterly CFO

-$8.00 M
+$20.88 M+72.30%

December 31, 2024


Summary


Performance

ABCL Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherABCLcash flowmetrics:

TTM CFO

-$108.56 M
+$11.61 M+9.66%

December 31, 2024


Summary


Performance

ABCL TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherABCLcash flowmetrics:

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

ABCL Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-147.4%+72.3%+9.7%
3 y3 years-144.4%+72.3%+9.7%
5 y5 years-4129.6%+72.3%+9.7%

ABCL Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-139.1%at low-102.9%+93.7%-131.0%+9.7%
5 y5-year-139.1%at low-102.9%+93.7%-131.0%+9.7%
alltimeall time-139.1%at low-102.9%+93.7%-131.0%+9.7%

AbCellera Biologics Cash From Operations History

DateAnnualQuarterlyTTM
Dec 2024
-$108.56 M(+147.4%)
-$8.00 M(-72.3%)
-$108.56 M(-9.7%)
Sep 2024
-
-$28.88 M(-3.6%)
-$120.17 M(+31.5%)
Jun 2024
-
-$29.97 M(-28.2%)
-$91.39 M(+120.1%)
Mar 2024
-
-$41.71 M(+112.7%)
-$41.52 M(-5.4%)
Dec 2023
-$43.88 M(-115.8%)
-$19.61 M(>+9900.0%)
-$43.88 M(-760.2%)
Sep 2023
-
-$106.00 K(-100.5%)
$6.65 M(-105.5%)
Jun 2023
-
$19.90 M(-145.2%)
-$120.03 M(-190.2%)
Mar 2023
-
-$44.06 M(-242.5%)
$133.08 M(-52.0%)
Dec 2022
$277.36 M
$30.91 M(-124.4%)
$277.36 M(+20.7%)
Sep 2022
-
-$126.79 M(-146.4%)
$229.74 M(-34.5%)
Jun 2022
-
$273.01 M(+172.4%)
$350.59 M(+49.0%)
DateAnnualQuarterlyTTM
Mar 2022
-
$100.22 M(-699.7%)
$235.26 M(-3.8%)
Dec 2021
$244.58 M(+977.9%)
-$16.71 M(+181.7%)
$244.58 M(-6.9%)
Sep 2021
-
-$5.93 M(-103.8%)
$262.57 M(-0.8%)
Jun 2021
-
$157.68 M(+43.9%)
$264.70 M(+99.0%)
Mar 2021
-
$109.55 M(+8471.6%)
$133.00 M(+486.2%)
Dec 2020
$22.69 M(+742.2%)
$1.28 M(-133.6%)
$22.69 M(+6.0%)
Sep 2020
-
-$3.80 M(-114.6%)
$21.41 M(-15.1%)
Jun 2020
-
$25.98 M(-3500.1%)
$25.21 M(-3400.1%)
Mar 2020
-
-$764.00 K
-$764.00 K
Dec 2019
$2.69 M(-24.4%)
-
-
Dec 2018
$3.56 M
-
-

FAQ

  • What is AbCellera Biologics annual cash flow from operations?
  • What is the all time high annual CFO for AbCellera Biologics?
  • What is AbCellera Biologics annual CFO year-on-year change?
  • What is AbCellera Biologics quarterly cash flow from operations?
  • What is the all time high quarterly CFO for AbCellera Biologics?
  • What is AbCellera Biologics quarterly CFO year-on-year change?
  • What is AbCellera Biologics TTM cash flow from operations?
  • What is the all time high TTM CFO for AbCellera Biologics?
  • What is AbCellera Biologics TTM CFO year-on-year change?

What is AbCellera Biologics annual cash flow from operations?

The current annual CFO of ABCL is -$108.56 M

What is the all time high annual CFO for AbCellera Biologics?

AbCellera Biologics all-time high annual cash flow from operations is $277.36 M

What is AbCellera Biologics annual CFO year-on-year change?

Over the past year, ABCL annual cash flow from operations has changed by -$64.68 M (-147.41%)

What is AbCellera Biologics quarterly cash flow from operations?

The current quarterly CFO of ABCL is -$8.00 M

What is the all time high quarterly CFO for AbCellera Biologics?

AbCellera Biologics all-time high quarterly cash flow from operations is $273.01 M

What is AbCellera Biologics quarterly CFO year-on-year change?

Over the past year, ABCL quarterly cash flow from operations has changed by +$20.88 M (+72.30%)

What is AbCellera Biologics TTM cash flow from operations?

The current TTM CFO of ABCL is -$108.56 M

What is the all time high TTM CFO for AbCellera Biologics?

AbCellera Biologics all-time high TTM cash flow from operations is $350.59 M

What is AbCellera Biologics TTM CFO year-on-year change?

Over the past year, ABCL TTM cash flow from operations has changed by +$11.61 M (+9.66%)